An express method of synthesis of surface-modified membrane composites is suggested that allows obtaining heterogeneous materials featuring effects of the blocking of the transport of solvent ions and molecules. Studies using the methods of atomic force microscopy (AFM), differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), and IR spectroscopy show that polyaniline is in the form of emeraldine and water at the interface of polyaniline aromatic chains and initial membrane sulfogroups is in a structured state due to formation of interpolymer complexes. This determines higher thermal stability of composites and specific morphology of the polyaniline layer. Measurement of electroosmotic and diffusion permeability and also membrane conductivity in HCl solutions (with the concentration of 0.01 to 2 M) shows the blocking effect of the polyaniline layer causing a significant decrease in transport characteristics in a wide range of concentrations of equilibrium solutions. A model of structural heterogeneity of composites is offered that takes into account the presence of an additional structural element, polyaniline, in the basic polymer matrix. Mechanisms of the observed barrier effects are discussed. Comparison of the transport-structural parameters of the MF-4SK membrane and MF-4SK/PAn composites allows elucidating the role of polyaniline in formation of transport routes for ion and solvent fluxes.

Polymer coatings based on polycations represent a perspective class of protective antimicrobial coatings. Polydiallyldimethylammonium chloride (PDADMAC) and its water-soluble complexes with sodium polystyrenesulfonate (PSS) were studied by means of dynamic light-scattering, laser microelectrophoresis and turbidimetry. It was shown that addition of six mol.% of polyanion to polycation results in formation of interpolyelectrolyte complex (IPEC) that was stable towards phase separation in water-salt media with a concentration of salts (NaCl, CaCl₂, Na₂SO₄, MgSO₄) up to 0.5 M. Most of the polyelectrolyte coatings are made by layer-by-layer deposition. The utilization of water-soluble IPEC for the direct deposition on the surface was studied. The coatings from the PDADMAC and the PSS/PDADMAC complex were formed on the surfaces of hydrophilic glass and hydrophobic polyvinylchloride. It was found that formation IPEC allows one to increase the stability of the coating towards wash-off with water in comparison to individual PDADMAC coating on both types of substrates. The visualization of the coatings was performed by atomic force microscopy and scanning electron microscopy.

Relaxation transitions in epoxy oligomers of various chemical nature and three-dimensional polymer networks on their basis are considered. Additional factors affecting relaxation of the networks, namely, the conversion of reactive functional groups of monomers during curing and the crosslink density of the network being formed, are discussed. Special attention is given to the phenomenon of physical aging in glassy crosslinked epoxy systems, which is analyzed from the experimental and theoretical viewpoints.

The aims of this study were to develop co-delivery systems of paclitaxel (PTX) and etoposide prodrug (4´-O-benzyloxycarbonyl-etoposide, ETP-cbz) based on non-cross-linked human serum albumin (HSA) and poly(lactide-co-glycolide) nanoparticles and to evaluate the synergistic potential of these drugs in vitro. The nanoformulations were prepared by the high-pressure homogenization technique and characterized using DLS, TEM, SEM, AFM, HPLC, CZE, in-vitro release, and cytotoxicity in human and murine glioma cells. All nanoparticles had 90-150 nm in size and negative ζ-potentials. The Neuro2A cells were the most sensitive to both HSA- and PLGA-based co-delivery systems (IC₅₀ 0.024 µM and 0.053 µM, respectively). The drugs’ synergistic effect (combination index < 0.9) was observed in the GL261 cells for both types of the co-delivery formulations and in the Neuro2A cells for the HSA-based system. These nanodelivery systems may be useful to improve combination chemotherapy for brain tumor treatment. To our knowledge, this is the first report describing the non-cross-linked HSA-based co-delivery nanosuspension which was prepared using nab™ technology.